These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26808419)

  • 1. Scaling factors for the in vitro-in vivo extrapolation (IV-IVE) of renal drug and xenobiotic glucuronidation clearance.
    Knights KM; Spencer SM; Fallon JK; Chau N; Smith PC; Miners JO
    Br J Clin Pharmacol; 2016 Jun; 81(6):1153-64. PubMed ID: 26808419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of in vitro glucuronidation clearance of a range of drugs in human kidney microsomes: comparison with liver and intestinal glucuronidation and impact of albumin.
    Gill KL; Houston JB; Galetin A
    Drug Metab Dispos; 2012 Apr; 40(4):825-35. PubMed ID: 22275465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
    Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
    Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The "albumin effect" and drug glucuronidation: bovine serum albumin and fatty acid-free human serum albumin enhance the glucuronidation of UDP-glucuronosyltransferase (UGT) 1A9 substrates but not UGT1A1 and UGT1A6 activities.
    Rowland A; Knights KM; Mackenzie PI; Miners JO
    Drug Metab Dispos; 2008 Jun; 36(6):1056-62. PubMed ID: 18362158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arbidol exhibits strong inhibition towards UDP-glucuronosyltransferase (UGT) 1A9 and 2B7.
    Liu X; Huang T; Chen JX; Zeng J; Fan XR; Xu-Zhu ; Yu ZW; Sun XY; Hong M; Sun HZ
    Pharmazie; 2013 Dec; 68(12):945-50. PubMed ID: 24400440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of UDP-glucuronosyltransferases 1A9 and 2B7 to the glucuronidation of indomethacin in the human liver.
    Mano Y; Usui T; Kamimura H
    Eur J Clin Pharmacol; 2007 Mar; 63(3):289-96. PubMed ID: 17245571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucuronidation of fenamates: kinetic studies using human kidney cortical microsomes and recombinant UDP-glucuronosyltransferase (UGT) 1A9 and 2B7.
    Gaganis P; Miners JO; Knights KM
    Biochem Pharmacol; 2007 May; 73(10):1683-91. PubMed ID: 17343829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucuronidation of icaritin by human liver microsomes, human intestine microsomes and expressed UDP-glucuronosyltransferase enzymes: identification of UGT1A3, 1A9 and 2B7 as the main contributing enzymes.
    Wang L; Hong X; Yao Z; Dai Y; Zhao G; Qin Z; Wu B; Gonzalez FJ; Yao X
    Xenobiotica; 2018 Apr; 48(4):357-367. PubMed ID: 28443723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Warfarin is an effective modifier of multiple UDP-glucuronosyltransferase enzymes: evaluation of its potential to alter the pharmacokinetics of zidovudine.
    Sun H; Zhang T; Wu Z; Wu B
    J Pharm Sci; 2015 Jan; 104(1):244-56. PubMed ID: 25393417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic microsomal UDP-glucuronosyltransferase (UGT) activities in the microminipig.
    Higashi E; Ando A; Iwano S; Murayama N; Yamazaki H; Miyamoto Y
    Biopharm Drug Dispos; 2014 Sep; 35(6):313-20. PubMed ID: 24752421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of niflumic acid as a selective inhibitor of human liver microsomal UDP-glucuronosyltransferase 1A9: application to the reaction phenotyping of acetaminophen glucuronidation.
    Miners JO; Bowalgaha K; Elliot DJ; Baranczewski P; Knights KM
    Drug Metab Dispos; 2011 Apr; 39(4):644-52. PubMed ID: 21245288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of 3'-azido-3'-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism.
    Court MH; Krishnaswamy S; Hao Q; Duan SX; Patten CJ; Von Moltke LL; Greenblatt DJ
    Drug Metab Dispos; 2003 Sep; 31(9):1125-33. PubMed ID: 12920168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human liver UDP-glucuronosyltransferase isoforms involved in the glucuronidation of 7-ethyl-10-hydroxycamptothecin.
    Hanioka N; Ozawa S; Jinno H; Ando M; Saito Y; Sawada J
    Xenobiotica; 2001 Oct; 31(10):687-99. PubMed ID: 11695848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucuronidation of macelignan by human liver microsomes and expressed UGT enzymes: identification of UGT1A1 and 2B7 as the main contributing enzymes.
    Liu H; Wu Z; Ma Z; Wu B
    Biopharm Drug Dispos; 2014 Dec; 35(9):513-24. PubMed ID: 25099990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of UDP-glucuronosyltransferases UGT1A9 and UGT2B7 in ethanol glucuronidation, and interactions with common drugs of abuse.
    Al Saabi A; Allorge D; Sauvage FL; Tournel G; Gaulier JM; Marquet P; Picard N
    Drug Metab Dispos; 2013 Mar; 41(3):568-74. PubMed ID: 23230132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro characterisation of human renal and hepatic frusemide glucuronidation and identification of the UDP-glucuronosyltransferase enzymes involved in this pathway.
    Kerdpin O; Knights KM; Elliot DJ; Miners JO
    Biochem Pharmacol; 2008 Jul; 76(2):249-57. PubMed ID: 18541222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vitro Characterization of Ertugliflozin Metabolism by UDP-Glucuronosyltransferase and Cytochrome P450 Enzymes.
    Lapham K; Callegari E; Cianfrogna J; Lin J; Niosi M; Orozco CC; Sharma R; Goosen TC
    Drug Metab Dispos; 2020 Dec; 48(12):1350-1363. PubMed ID: 33020067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enantiomer selective glucuronidation of the non-steroidal pure anti-androgen bicalutamide by human liver and kidney: role of the human UDP-glucuronosyltransferase (UGT)1A9 enzyme.
    Grosse L; Campeau AS; Caron S; Morin FA; Meunier K; Trottier J; Caron P; Verreault M; Barbier O
    Basic Clin Pharmacol Toxicol; 2013 Aug; 113(2):92-102. PubMed ID: 23527766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between human UDP-glucuronosyltransferase (UGT) 2B7 and UGT1A enzymes.
    Fujiwara R; Nakajima M; Oda S; Yamanaka H; Ikushiro S; Sakaki T; Yokoi T
    J Pharm Sci; 2010 Jan; 99(1):442-54. PubMed ID: 19475557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bovine serum albumin decreases Km values of human UDP-glucuronosyltransferases 1A9 and 2B7 and increases Vmax values of UGT1A9.
    Manevski N; Moreolo PS; Yli-Kauhaluoma J; Finel M
    Drug Metab Dispos; 2011 Nov; 39(11):2117-29. PubMed ID: 21856742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.